All Updates

All Updates

icon
Filter
FDA approval
Momentis Surgical receives FDA clearance for second-gen Anovo surgical robot
Next-gen Medical Devices
Nov 11, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Next-gen Medical Devices

Next-gen Medical Devices

Nov 11, 2024

Momentis Surgical receives FDA clearance for second-gen Anovo surgical robot

FDA approval

  • Momentis Surgical has received FDA clearance for its second-gen Anovo robotic surgical platform. The system features miniature humanoid-shaped robotic arms and is the first FDA-cleared robotic system capable of operating in retroflexion and anteflexion.

  • The upgraded platform includes new features such as integrated haptic feedback for intuitive control, enhanced ergonomics, and an annotation-enabled video overlay system for improved team communication. The system was previously authorized only for single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures.

  • Analyst QuickTake: Several FDA approvals for next-gen medical devices were seen in the recent past. In October 2024, CMR Surgical received FDA marketing clearance for its Versius surgical robotic system. In August 2024 , THINK Surgical's TMINI Miniature Robotic System was cleared for use with Medacta International’s GMK Sphere and SpheriKA Knee Systems.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.